KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Enterprise Value (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Enterprise Value for 17 consecutive years, with -$1.5 billion as the latest value for Q4 2025.

  • Quarterly Enterprise Value rose 7.44% to -$1.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.5 billion through Dec 2025, up 7.44% year-over-year, with the annual reading at -$1.5 billion for FY2025, 7.44% up from the prior year.
  • Enterprise Value for Q4 2025 was -$1.5 billion at Bio-Rad Laboratories, down from -$1.4 billion in the prior quarter.
  • The five-year high for Enterprise Value was -$395.6 million in Q2 2023, with the low at -$2.1 billion in Q1 2022.
  • Average Enterprise Value over 5 years is -$1.1 billion, with a median of -$1.0 billion recorded in 2021.
  • Peak annual rise in Enterprise Value hit 76.3% in 2024, while the deepest fall reached 306.57% in 2024.
  • Over 5 years, Enterprise Value stood at -$476.4 million in 2021, then increased by 7.68% to -$439.8 million in 2022, then grew by 6.91% to -$409.4 million in 2023, then crashed by 306.57% to -$1.7 billion in 2024, then grew by 7.44% to -$1.5 billion in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$1.5 billion, -$1.4 billion, and -$1.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.